Ackman says Allergan holders back takeover at $180/shr: CNBC
Activist investor William Ackman on Monday defended Valeant Pharmaceuticals during an interview on CNBC television and said that Allergan Inc shareholders told him they would support a deal at $180 per share.
No comments:
Post a Comment